Comparison of teriparatide and calcitonin in the treatment of men and postmenopausal women with osteoporosis

Trial Profile

Comparison of teriparatide and calcitonin in the treatment of men and postmenopausal women with osteoporosis

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Teriparatide (Primary) ; Calcitonin
  • Indications Male osteoporosis; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 06 Mar 2008 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top